Establishment and clinical application of enzyme immunoassays for determination of luteinizing hormone releasing hormone and metastin

Journal of Peptide Science

Volumn 13, Issue 6, 2007, Pages 422-429

  Katagiri, Fumihiko ^a   Tomita, Kenji ^b   Oishi, Shinya ^b   Takeyama, Masaharu ^a   Fujii, Nobutaka ^b  

^a OITA UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Clinical application; Enzyme immunoassay; Isolated hypogonadotropic hypogonadism; Luteinizing hormone releasing hormone; Metastin

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; GENE PRODUCT; GONADORELIN ACETATE; HYPOCRINE; KISSPEPTIN 10; METASTIN; METASTIN 10; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTERMITTENT THERAPY; DRUG MILK LEVEL; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IMMUNOREACTIVITY; MALE; NEUROENDOCRINOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTION; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADULT; AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNE SERA; IMMUNOENZYME TECHNIQUES; MALE; MOLECULAR SEQUENCE DATA; PREGNANCY; TUMOR SUPPRESSOR PROTEINS;

EID: 34250193702     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.863     Document Type: Article

References (23)

1. de-Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 1997; 337: 1597-1602.
2. Beranova V, Oliveria LM, Bedecarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley WF, Seminara SB Jr. Prevalence, phenotype spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2001; 86: 1580-1588.
3. de-Roux N, Gemin R, Carel JC, Matsuda F, Chaussain JL, Milgrom, E. Hypogonadotropic hypogonadism due to loss of function of the KISS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 10972-10976.
4. Seminara SB, Messager S, Chatzidaki EE, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kouhung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Calton MB, Crowley WF Jr, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 2003; 339: 1614-1627.
5. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vandenwinden JM, Le Poul E, Brezillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 2001; 276: 34631-34636.
6. Harms JF, Welch DR, Miele ME. KISS1 metastasis suppression and emergent pathways. Clin. Exp. Metastasis 2003; 20: 11-18.
7. Niida A, Wang Z, Tomita K, Oishi S, Tamamura H, Otaka A, Navenot JM, Broach JR, Peiper SC, Fujii N. Design and synthesis of downsizing metastin (45-54) analogs with maintenance of high GPR54 agonistic activity. Bioorg. Med. Chem. Lett. 2006; 16: 134-137 references cited in.
8. Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot J-M, Wang Z, Peiper SC, Fujii N. Structure-activity relationship study on small peptidic GPR54 agonist. Bioorg. Med. Chem. 2006; 14: 7595-7603.
9. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J. Natl. Cancer Inst. 1996; 88: 1731-1737.
10. Dungan HM, Clifton DK, Steiner RA. Minireview: Kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion. Endocrinology 2006; 147: 1154-1158 references cited in.
11. Nakai Y, Plant TM, Hess DL, Keogh EJ, Knobil E. On the sites of the negative and positive feedback actions of estradiol in the control of gonadotropin secretion in the rhesus monkey. Endocrinology 1978; 107: 1008-1014.
12. Jacobson RL, Seyler LE Jr, Tamborlane WV Jr, Gertner JM, Genel M. Pulsatile subcutaneous nocturnal administration of GnRH by portable infusion pump in hypogonadotropic hypogonadism; initiation of gonadotropin responsiveness. J. Clin. Endocrinol. Metab. 1979; 46: 652-654.
13. Valk TW, Colrey KP, Kelch RP, Marshall JC. Hypogonadotropic hypogonadism; hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone. J. Clin. Endocrinol. Metab. 1980; 51: 730-738.
14. Hoffmann AR, Crowley WF. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N. Engl. J. Med. 1982; 307: 1237-1241.
15. Kitagawa T, Shimozono T, Aikawa T, Yoshida T, Nishimura H. Preparation and characterization of hetero-bifunctional cross-linking reagents for protein modifications. Chem. Pharm. Bull. 1981; 29: 1130-1135.
16. Tat HH, Chey WY. Development of radioimmunoassay for motilin. Anal. Biochem. 1978; 87: 350-358.
17. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, Fujino M. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J. Clin. Endocrinol. Metab. 2003; 88: 914-919.
18. Kinoshita M, Tsukamura H, Adachi S, Matsui H, Uenoyama Y, Iwata K, Yamada S, Inoue K, Ohtaki T, Matsumoto H, Maeda K. Involvement of central metastin in the regulation of preovulatory leuteinizing hormone surge and estrous cyclicity on female rats. Endocrinology 2005; 146: 4431-4436.
19. Hsueh AJ, Jones PB. Extrapituitary actions of gonadotropin-releasing hormone. Endocr. Rev. 1981; 2: 437-461.
20. Fauser BCJM, Rolland R, Thomas CMG, Doesburg WH, Dony JMJ. Serum luteinizing hormone-releasing hormone (LH-RH) and gonadotropic hormones in men after a bolus dose of LH-RH: comparison of different doses and routes of administration. Fertil. Steril. 1985; 44: 384-389.
21. Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog. Horm. Res. 1980; 36: 53-85.
22. Stathatos N, Bourdeau I, Espinosa VA, Saji M, Vasko VV, Burman KD, Stratakis CA, Ringel MD. KiSS-1/G protein-couplcd receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J. Clin. Endocrinol. Metab. 2005; 90: 5432-5440 reference cited in.
23. Smith JT, Dungan HM, Stoll EA, Gottsch ML, Braun PE, Eacker SM, Clifton DK, Steiner RA. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology 2005; 146: 2976-2984.